Nalaganje...
A rare cutaneous adverse effect secondary to cabozantinib therapy
Cabozantinib is a tyrosine kinase inhibitor which is increasingly being used for the treatment of metastatic renal cell cancer. Skin toxicity such as palmar-plantar erythrodysesthesia is not uncommon with such agents. However, bullous skin reactions are not common and we report the case of a patient...
Shranjeno v:
| izdano v: | Oxf Med Case Reports |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Oxford University Press
2018
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6252307/ https://ncbi.nlm.nih.gov/pubmed/30487990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/omcr/omy105 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|